Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial

Christoph Kapitza; Kirsten Dahl; Jacob B. Jacobsen; Mads B. Axelsen; Anne Flint

doi:10.1007/s00125-017-4289-0

Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial

Diabetologia ◽

10.1007/s00125-017-4289-0 ◽

2017 ◽

Vol 60 (8) ◽

pp. 1390-1399 ◽

Cited By ~ 29

Author(s):

Christoph Kapitza ◽

Kirsten Dahl ◽

Jacob B. Jacobsen ◽

Mads B. Axelsen ◽

Anne Flint

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The suppression of TXNIP and miR-200c improve beta-cell function in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Journal of Functional Foods ◽

10.1016/j.jff.2018.07.019 ◽

2018 ◽

Vol 48 ◽

pp. 481-489 ◽

Cited By ~ 1

Author(s):

Neda Roshanravan ◽

Reza Mahdavi ◽

Mohammad Asghari Jafarabadi ◽

Effat Alizadeh ◽

Shahriar Alipour ◽

...

Keyword(s):

Type 2 Diabetes ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Download Full-text

The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial

BMC Public Health ◽

10.1186/1471-2458-13-999 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 3

Author(s):

Ravi K Menon ◽

Anna P Rickard ◽

Nasima Mannan ◽

Peter M Timms ◽

Stephen J Sharp ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Controlled Trial ◽

Metabolic Parameters ◽

Vitamin D2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12625 ◽

2016 ◽

Vol 18 (4) ◽

pp. 392-400 ◽

Cited By ~ 43

Author(s):

N. G. Forouhi ◽

R. K. Menon ◽

S. J. Sharp ◽

N. Mannan ◽

P. M. Timms ◽

...

Keyword(s):

Type 2 Diabetes ◽

At Risk ◽

Glycaemic Control ◽

Cardiometabolic Risk ◽

Controlled Trial ◽

Vitamin D2 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718556007.793521855 ◽

2016 ◽

Author(s):

Frank Lammert

Keyword(s):

Type 2 Diabetes ◽

Beta Cell Function ◽

Cell Function ◽

Controlled Trial ◽

Vitamin D Insufficiency ◽

High Dose ◽

Double Blind ◽

Metabolic Markers ◽

High Dose Vitamin

Download Full-text

Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education

QJM ◽

10.1093/qjmed/93.3.183 ◽

2000 ◽

Vol 93 (3) ◽

pp. 183-190 ◽

Cited By ~ 22

Author(s):

W.B. CHAN

Keyword(s):

Type 2 Diabetes ◽

Body Weight ◽

Patient Education ◽

Glycaemic Control ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

The Impact

Download Full-text

Effects of 12weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

Metabolism ◽

10.1016/j.metabol.2014.06.008 ◽

2014 ◽

Vol 63 (9) ◽

pp. 1115-1124 ◽

Cited By ~ 82

Author(s):

Ulla Kampmann ◽

Leif Mosekilde ◽

Claus Juhl ◽

Niels Moller ◽

Britt Christensen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Beta Cell Function ◽

Cell Function ◽

Controlled Trial ◽

Vitamin D Insufficiency ◽

High Dose ◽

Double Blind ◽

Metabolic Markers ◽

High Dose Vitamin

Download Full-text

Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3‐ year follow‐up of the Qatar study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14153 ◽

2020 ◽

Vol 22 (12) ◽

pp. 2287-2294

Author(s):

Muhammad Abdul‐Ghani ◽

Osama Migahid ◽

Ayman Megahed ◽

Ralph A. DeFronzo ◽

Ebaa Al‐Ozairi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Combination Therapy ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Bolus Insulin ◽

Basal Bolus

Download Full-text

Early intensified insulin therapy in newly diagnosed type 2 diabetes leads to sustained improvement in glycaemic control and improved beta cell function

Clinical Medicine ◽

10.7861/clinmedicine.19-2-s120 ◽

2019 ◽

Vol 19 (Suppl 2) ◽

pp. s120-s120

Author(s):

Jatinder Mokta

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Beta Cell ◽

Insulin Therapy ◽

Beta Cell Function ◽

Cell Function ◽

Newly Diagnosed ◽

Sustained Improvement ◽

Intensified Insulin Therapy

Download Full-text